Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Biochimica Et Biophysica Acta|April 15, 2014
Prostate-specific antigen and other serum and urine markers in prostate cancerCarsten Stephan, Bernhard Ralla, Klaus Jung
Clinical Chemistry and Laboratory Medicine|April 17, 2012
Assay-dependent abnormalities in measurements of prostate-specific antigen in serum: an occasional occurrence, but of clinical significanceKlaus Jung, Carsten Stephan, Michael Lein
Future Oncology (London, England)|September 12, 2015
Current biomarkers for diagnosing of prostate cancerCarsten Stephan, Klaus Jung, Bernhard Ralla
Der Urologe. Ausg. A|June 22, 2018
[Reply to: PSA screening : Possible uses and harm by N. Keller, M. Jenny, G. Gigerenzer, R. Ablin]Carsten Stephan, Thorsten Schlomm, Klaus Jung
European Urology|July 29, 2015
Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039Carsten Stephan, Henning Cammann, Klaus Jung
Nature Clinical Practice. Urology|February 14, 2006
Artificial neural networks: has the time come for their use in prostate cancer patients?Carsten Stephan, Henning Cammann, Klaus Jung
Clinical Chemistry and Laboratory Medicine|August 17, 2013
Research forever - Klaus JungCarsten Stephan, Eleftherios P Diamandis, Glen Kristiansen
Urology|October 18, 2008
Re: Al-Azab R, Toi A, Lockwood G, et al. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL (Urology 69:103-107, 2007)Carsten Stephan, Klaus Jung, Michael Lein, et al.
Journal of Clinical Laboratory Analysis|January 4, 2023
Prostate volume and its influence on clinical parameters in prostate cancer detectionCarsten Stephan, Robert Peters, Klaus Jung, et al.
International Journal of Molecular Sciences|May 25, 2024
Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature DataAnnika Fendler, Carsten Stephan, Bernhard Ralla, et al.
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Biochimica Et Biophysica Acta|April 15, 2014
Prostate-specific antigen and other serum and urine markers in prostate cancerCarsten Stephan, Bernhard Ralla, Klaus Jung
Clinical Chemistry and Laboratory Medicine|April 17, 2012
Assay-dependent abnormalities in measurements of prostate-specific antigen in serum: an occasional occurrence, but of clinical significanceKlaus Jung, Carsten Stephan, Michael Lein
Future Oncology (London, England)|September 12, 2015
Current biomarkers for diagnosing of prostate cancerCarsten Stephan, Klaus Jung, Bernhard Ralla
Der Urologe. Ausg. A|June 22, 2018
[Reply to: PSA screening : Possible uses and harm by N. Keller, M. Jenny, G. Gigerenzer, R. Ablin]Carsten Stephan, Thorsten Schlomm, Klaus Jung
European Urology|July 29, 2015
Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039Carsten Stephan, Henning Cammann, Klaus Jung
Nature Clinical Practice. Urology|February 14, 2006
Artificial neural networks: has the time come for their use in prostate cancer patients?Carsten Stephan, Henning Cammann, Klaus Jung
Clinical Chemistry and Laboratory Medicine|August 17, 2013
Research forever - Klaus JungCarsten Stephan, Eleftherios P Diamandis, Glen Kristiansen
Urology|October 18, 2008
Re: Al-Azab R, Toi A, Lockwood G, et al. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL (Urology 69:103-107, 2007)Carsten Stephan, Klaus Jung, Michael Lein, et al.
Journal of Clinical Laboratory Analysis|January 4, 2023
Prostate volume and its influence on clinical parameters in prostate cancer detectionCarsten Stephan, Robert Peters, Klaus Jung, et al.
International Journal of Molecular Sciences|May 25, 2024
Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature DataAnnika Fendler, Carsten Stephan, Bernhard Ralla, et al.
Pageof 23